MRX gets the right to distribute Reloxin for a fraction of what they originally intended to spend. Reloxin and Restylane will compliment each other being that they serve different purposes. Reloxin will go head-to head with Botox. MRX CEO is interviewed by Cramer and refers to a "Sea of products" coming down the pipeline. Anyone who watches Cramer knows that, after his short interviews with CEO's, he isn't shy about exposing their B.S. or telling viewers to avoid the stock. Cramer was very enthusiastic about MRX. Also, if you didn't know, MRX will ring the NYSE bell Wednesday morning along with Ipsen. No monetary value attached to that, but it goes to show the enthusiasm at MRX. I think MRX is for real. Although I'm a bit conservative, I think the stock will hit $45 by year-end.